Cencora (COR) YTD return
Updated November 02, 2026 · Data: Yahoo Finance
Price chart
COR vs its sector
Underperforming its sector. COR is 29.11 points behind the Health Care sector average, which covers 60 ranked S&P 500 stocks.
Cencora (COR) is up +0.62% year-to-date in 2026, ranking #347 of 500 ranked S&P 500 stocks. It closed 2025 at $335.75 and trades at $337.84 as of November 02, 2026. $1,000 invested on December 31, 2025 would be worth $1,006.20 today. That puts it 29.11 points behind the Health Care sector average of +29.73%.
Recent performance
Cencora (COR) has gained 9.32% over the past month, outpacing the S&P 500 by 11.66%, and gained 10.52% over the past three months (ahead of the index by 13.04%). It is trading 9.31% below its 52-week high of $372.53, set on 2025-11-25.
Latest COR news
- Cencora (COR) Stock Still Looks Undervalued After Its 173% RunSimply Wall St. · 2026-11-01
- Is Cencora (COR) Fully Valued Following Its $2.4b American Oncology Network Deal?Simply Wall St. · 2026-11-01
- What Does Cencora (COR) Gain From Expanding Into 12 More States?Simply Wall St. · 2026-10-31
- 2 large-cap stocks with impressive fundamentals and 1 we ignoreStockStory · 2026-10-30
- Cencora Gears Up to Report Q4 Results: How to Play the Stock?Zacks · 2026-10-30
Headlines via Yahoo Finance, updated daily.
Where to invest in COR
Popular stock brokerages:
We may earn a commission if you sign up through these links, at no extra cost to you.
COR YTD return FAQ
What is Cencora (COR)'s YTD return in 2026?
Cencora (COR) is up +0.62% year-to-date in 2026, as of November 02, 2026.
What was Cencora (COR)'s price at the start of 2026?
Cencora (COR) closed at $335.75 on December 31, 2025 and trades at $337.84 as of November 02, 2026.
Where does Cencora (COR) rank by YTD return in 2026?
Cencora (COR) ranks #347 of 500 S&P 500 stocks by YTD return in 2026, as of November 02, 2026.
For informational purposes only, not financial advice.
About · Contact · Privacy Policy · Affiliate Disclosure · Methodology
© 2026 MZX MEDIA LLC. All rights reserved.